Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?

Chair, Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)581-583
Number of pages3
JournalEye (Basingstoke)
Issue number4
StatePublished - Mar 2023


  • Humans
  • Angiogenesis Inhibitors/therapeutic use
  • Ranibizumab/therapeutic use
  • Macular Degeneration/drug therapy
  • Intravitreal Injections
  • Wet Macular Degeneration/drug therapy
  • Tomography, Optical Coherence
  • Treatment Outcome

ASJC Scopus subject areas

  • Sensory Systems
  • Ophthalmology

Cite this